Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Artivion Inc.
Study ID
NCT07089576
Status
Recruiting

Conditions

  • Acute Aortic Dissection
  • Aortic Arch Aneurysm
  • Aortic Arch Dissection
  • Chronic Aortic Dissection

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Arcevo™ LSA Hybrid Stent Graft System — DEVICE
    The Arcevo LSA Hybrid Stent Graft System is an implantable aortic stent graft with LSA branch which is preloaded onto a delivery system and implanted during an open surgical procedure, or more specifically a total arch replacement procedure. The device is intended for use with a proximal surgical graft (not supplied). If additional coverage is needed, a protocol specified thoracic endovascular aortic repair (TEVAR) device may be used.

Study Details

The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.

Key Dates

Start date
Nov 4, 2025
Status verified
May 2026
Primary completion
Apr 30, 2028
Completion
Jul 31, 2032

Study Design

Enrollment
132 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Arcevo LSA
    The Primary study arm will consist of patients with an aortic aneurysm or chronic aortic dissection (n=117). The Secondary study arm will include patients with acute or subacute aortic dissections (n=15).

Primary Outcome Measure

Composite Rate of Patients Free From ≥1 Major Adverse Event [ Time Frame: 1 year post-index procedure of LSA stent graft implant ]

Central Contacts

Locations (19)

FacilityCityStateZIPSite coordinators
University of AlabamaBirminghamAlabama35205
Marissa Waite
205-659-5660
Kyle Eudailey, MD (PRINCIPAL_INVESTIGATOR)
University of Southern CaliforniaLos AngelesCalifornia90033
Stephanie Varela
213-655-0998
Fernando Fleischman, MD (PRINCIPAL_INVESTIGATOR)
University of Colorado HospitalAuroraColorado80045
Tien Ngo
303-724-5020
T. Brett Reece, MD (PRINCIPAL_INVESTIGATOR)
MedStar Washington HealthWashington D.C.District of Columbia20010
Katharine Mahoney
202-877-2806
Christian Shults, MD (PRINCIPAL_INVESTIGATOR)
Emory University School of MedicineAtlantaGeorgia30322
Kim Baio
404-686-3374
Bradley Leshnower, MD (PRINCIPAL_INVESTIGATOR)
Northwestern University Feinberg School of MedicineChicagoIllinois60611
Andrea Silverman
312-926-4000
Christopher Malaisrie, MD (PRINCIPAL_INVESTIGATOR)
Johns Hopkins HospitalBaltimoreMaryland21287
Lisa Fornaresio
443-927-3984
Mehrdad Ghoreishi, MD (PRINCIPAL_INVESTIGATOR)
University of MichiganAnn ArborMichigan48109
China Green
734-936-7731
Shinichi Fukuhara, MD (PRINCIPAL_INVESTIGATOR)
Columbia University Irving Medical Center/New York Presbyterian HospitalNew YorkNew York10032
Amanda Alonso
212-342-0261
Hiroo Takayama, MD, PhD (PRINCIPAL_INVESTIGATOR)
Cornell Medical College (Presbyterian Weill)New YorkNew York10065
Marshagay Rodriguez
212-746-5594
Christopher Lau, MD (PRINCIPAL_INVESTIGATOR)
Northwell HealthNew YorkNew York10075
Michelle Vovsha
212-434-2726
Derek Brinster, MD (PRINCIPAL_INVESTIGATOR)
Montefiore Medical CenterThe BronxNew York10467
Magdalena Mamczur-Madry
718-920-3576
Joseph DeRose, MD (PRINCIPAL_INVESTIGATOR)
Cleveland Clinic FoundationClevelandOhio44195
Laurie Moennich, PhD
216-444-2106
Patrick Vargo, MD, FACS (PRINCIPAL_INVESTIGATOR)
Allegheny General HospitalPittsburghPennsylvania15212
Tracy Spirk
412-359-4025
Michael Halbreiner, MD (PRINCIPAL_INVESTIGATOR)
University of Texas - AustinAustinTexas78705
Andrea Stapper, MBA
512-324-1000
George Arnaoutakis, MD (PRINCIPAL_INVESTIGATOR)
University of Texas, McGovern Medical CenterHoustonTexas77030
Mariano Montemayor
713-486-5194
Anthony Estrera, MD (PRINCIPAL_INVESTIGATOR)
Baylor Scott & WhitePlanoTexas75093
Walter Cerqueira
469-814-3393
Bill Brinkman, MD (PRINCIPAL_INVESTIGATOR)
University of Washington / Harborview Medical CenterSeattleWashington98105
Alex Ruiz
206-221-3883
Chris Burke, MD (PRINCIPAL_INVESTIGATOR)
Medical College of WisconsinMilwaukeeWisconsin53226
Kelly Potzner
414-955-1848
Jorge Mascaro, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Birmingham, AL

Related Studies